Trial intelligence / Profile preview

Nasonex for Asthma Control in Patients with Chronic Rhinitis or Sinusitis (STAN)

NCT01118312Phase 4Completed

Sponsor
Johns Hopkins Center for Clinical Trials and Evidence Synthesis
Start
Sep 2010
Primary completion
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mometasone furoate nasal spray in rhinitis, sinusitis, sponsored by Johns Hopkins Center for Clinical Trials and Evidence Synthesis. Started Sep 2010; status: completed.

02

Drugs

mometasone furoate nasal spray
03

Conditions

rhinitissinusitis

Beyond the preview

Go deeper on NCT01118312.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01118312.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call